Rapid Decompression Sickness Chamber Global Market Report 2025

The rapid decompression sickness chamber market size has grown rapidly in recent years. It will grow from $1.35 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 11%. The growth during the historic period is attributed to the rising incidence of diving accidents, expansion of commercial offshore industries, stringent occupational safety regulations, increasing military investment in dive medicine, and growing participation in recreational scuba diving.

The rapid decompression sickness chamber market size is expected to see rapid growth in the next few years. It will grow to $2.25 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth during the forecast period is attributed to the rising global burden of diabetic foot ulcers, expanding clinical applications for neurological conditions, increasing geriatric population with vascular complications, growing adoption in sports medicine recovery protocols, and rising healthcare infrastructure development in emerging economies. Key trends in the forecast period include the development of compact, portable chambers for emergency field use, integration of artificial intelligence for automated treatment protocols, expansion of telemedicine capabilities for remote monitoring, and the introduction of next-generation decompression chambers.

The expanding maritime activities are expected to drive the growth of the rapid decompression sickness chamber market. Maritime activities include all sea-based operations and services, such as shipping, fishing, port management, and offshore industries. The increase in maritime operations is fueled by growing global trade, as the rising movement of goods by ships provides a cost-effective and efficient means to connect international markets, boosting demand for ports, vessels, and marine services. Rapid decompression sickness (RDS) chambers support maritime operations by treating divers and crew exposed to sudden pressure changes, ensuring quick recovery from decompression sickness, minimizing downtime, and maintaining safe operations in underwater and offshore environments. For example, in March 2025, the United States Naval Institute reported that maritime trade volume is projected to rise by 2% in 2024, while container trade is expected to grow by 2.7%. The growth of maritime activities is therefore contributing to the expansion of the rapid decompression sickness chamber market.

Key companies in the rapid decompression sickness chamber market are focusing on advancements in hyperbaric treatment and patient care to enhance treatment efficacy, reduce recovery time, and improve patient safety. Hyperbaric oxygen therapy (HBOT) is a procedure that delivers pure oxygen under increased atmospheric pressure, improving oxygen absorption in the blood and supporting tissue repair and recovery. For example, in January 2024, Sechrist Industries Inc., a US-based manufacturer, launched the 3300HM hyperbaric chamber and the eHEAL system to improve treatment efficiency and patient care. The eHEAL software automates hyperbaric treatment logging, enhancing accuracy, efficiency, and real-time data capture to reduce errors and administrative workload. The 3300HM hyperbaric chamber features a modern step-in design for improved accessibility, integrated safety technologies, and flexible compression options, offering easy operation. Together, these products optimize treatment workflow, patient safety, and clinical data management, advancing hyperbaric medicine with greater precision and user-friendliness.

In July 2023, O2 Worx Ltd., a UK-based manufacturer, partnered with Submarine Manufacturing and Products Limited (SMP) to enhance the production and safety of hyperbaric and submarine systems. The partnership aims to accelerate the growth and deployment of O2 Worx’s hyperbaric oxygen chambers by expanding access to advanced, non-invasive oxygen therapy in health, wellness, and sports markets, supported by SMP's expertise and distribution network. Submarine Manufacturing and Products Limited (SMP), also based in the UK, provides rapid decompression sickness chambers.

Major players in the rapid decompression sickness chamber market are IHC Hytech BV., Shanghai Baobang Medical Equipment Co. Ltd., Sechrist Industries Inc., Perry Baromedical Corporation, Drass Galeazzi Srl, SOS Medical, HiperTech Electronics Inc., Comanex, Oxycare, Haux Life Support GmbH., Hyperbaric, Fink Engineering Pty. Ltd., Gulf Coast Hyperbarics Inc., Hearmec Co. Ltd., HPO TECH, iSubC Diving Equipment Ltd., Khrunichev Medical Equipment Plant JSC., OxyHeal Health Group Inc., PBUCH S.A., Tekna Manufacturing LLC, BAROKS A.Ş., and Oxybarica.

North America was the largest region in the rapid decompression sickness chamber market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in rapid decompression sickness (RDS) chamber report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The rapid decompression sickness chamber market research report is one of a series of new reports that provides rapid decompression sickness chamber market statistics, including rapid decompression sickness chamber industry global market size, regional shares, competitors with a rapid decompression sickness chamber market share, detailed rapid decompression sickness chamber market segments, market trends and opportunities, and any further data you may need to thrive in the rapid decompression sickness chamber industry. This rapid decompression sickness chamber market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A rapid decompression sickness (RDS) chamber is a medical or hyperbaric chamber designed to treat decompression sickness caused by sudden pressure drops, which lead to nitrogen bubbles forming in the bloodstream and tissues. It provides a controlled high-pressure environment to reduce nitrogen bubbles, relieve symptoms, and prevent tissue damage.

The primary types of rapid decompression sickness chambers include monoplace chambers, multiplace chambers, portable chambers, and others. Monoplace chambers are hyperbaric oxygen therapy units designed for single-patient treatment, delivering 100% oxygen under elevated atmospheric pressure within a sealed, pressurized enclosure. These chambers incorporate manual and automated technologies. They are used in hospitals, military and defense, diving centers, research and academic institutes, and other applications, serving end users such as healthcare facilities, emergency services, the military, and more.

The countries covered in the rapid decompression sickness (RDS) chamber market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rapid decompression sickness (RDS) chamber market consists of revenues earned by entities by providing services such as emergency recompression therapy, hyperbaric oxygen therapy, and monitoring and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The rapid decompression sickness (RDS) chamber market also includes sales of hyperbaric oxygen delivery systems, pressure control systems, and patient monitoring equipment. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.